PTGS2 and cardiac hypertrophy: ERK5 activates MEF2, which, as demonstrated by Lee et al., promotes the expression of heparin-binding epidermal growth factor-like growth factor (HB-EGF)-induced cyclooxygenase-2 (COX-2), further inducing cardiac hypertrophy.